NO20010119L - Preparater omfattende GABA-analoger og kaffein - Google Patents

Preparater omfattende GABA-analoger og kaffein

Info

Publication number
NO20010119L
NO20010119L NO20010119A NO20010119A NO20010119L NO 20010119 L NO20010119 L NO 20010119L NO 20010119 A NO20010119 A NO 20010119A NO 20010119 A NO20010119 A NO 20010119A NO 20010119 L NO20010119 L NO 20010119L
Authority
NO
Norway
Prior art keywords
caffeine
preparations
gaba analogues
gaba
analogues
Prior art date
Application number
NO20010119A
Other languages
English (en)
Norwegian (no)
Other versions
NO20010119D0 (no
Inventor
Leslie Magnus-Miller
Catherine A Segal
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO20010119D0 publication Critical patent/NO20010119D0/no
Publication of NO20010119L publication Critical patent/NO20010119L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20010119A 1998-07-09 2001-01-08 Preparater omfattende GABA-analoger og kaffein NO20010119L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9213198P 1998-07-09 1998-07-09
PCT/US1999/013670 WO2000002562A1 (en) 1998-07-09 1999-06-18 Compositions comprising gaba analogs and caffeine

Publications (2)

Publication Number Publication Date
NO20010119D0 NO20010119D0 (no) 2001-01-08
NO20010119L true NO20010119L (no) 2001-01-08

Family

ID=22231777

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010119A NO20010119L (no) 1998-07-09 2001-01-08 Preparater omfattende GABA-analoger og kaffein

Country Status (13)

Country Link
US (1) US6326374B1 (xx)
EP (1) EP1094817A1 (xx)
JP (1) JP2002520286A (xx)
KR (1) KR20010071777A (xx)
AU (1) AU772156B2 (xx)
BR (1) BR9911917A (xx)
CA (1) CA2332915C (xx)
ID (1) ID28277A (xx)
NO (1) NO20010119L (xx)
NZ (1) NZ508490A (xx)
PL (1) PL345340A1 (xx)
WO (1) WO2000002562A1 (xx)
ZA (1) ZA200007168B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1094757C (zh) 1996-07-24 2002-11-27 沃尼尔·朗伯公司 用于治疗疼痛的异丁基γ－氨基丁酸及其衍生物
US6992109B1 (en) * 1999-04-08 2006-01-31 Segal Catherine A Method for the treatment of incontinence
ATE303162T1 (de) * 1999-04-09 2005-09-15 Euro Celtique Sa Natrium kanalblocker zusammensetzungen und deren verwendung
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
AU2002333374B2 (en) 2001-09-03 2007-03-22 Newron Pharmaceuticals S.P.A. Pharmaceutical composition comprising gabapentin or an analogue thereof and an (alpha)- aminoamide and its analgesic use
RU2335342C2 (ru) * 2004-03-12 2008-10-10 Уорнер-Ламберт Компани Ллс C1-симметричные бисфосфиновые лиганды и их применение в асимметрическом синтезе прегабалина
ATE405572T1 (de) * 2004-04-01 2008-09-15 Warner Lambert Co Herstellung von p-chirogenen phospholanen und deren verwendung in der asymmetrischen synthese
ME01067B (me) * 2004-06-21 2012-10-20 Warner Lambert Co Dobijanje pregabalina i srodnih jedinjenja
SI1809271T1 (sl) * 2004-09-10 2010-10-29 Newron Pharm Spa Uporaba (R)-(halobenziloksi) benzilamino propanamidov kot selektivnih modulatorjev natrijevih in/ali kalcijevih kanalov
RS54522B1 (en) 2005-12-22 2016-06-30 Newron Pharmaceuticals S.P.A. 2-Phenylethylamino Derivatives as Modulators of Calcium and (or Sodium) Channels
US7645767B2 (en) * 2006-08-31 2010-01-12 Trinity Laboratories, Inc. Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
CH699327B1 (de) 2007-02-14 2010-03-15 Oerlikon Heberlein Temco Wattw Vorrichtung zum gleichzeitigen Behandeln von mehreren multifilen Fäden.
EP2184986A4 (en) 2007-08-06 2010-12-15 Trinity Lab Inc PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHRONIC PAIN AND PAIN RELATING TO NEUROPATHY
JP2010043063A (ja) * 2008-05-09 2010-02-25 Agency For Science Technology & Research 川崎病の診断及び治療
US20100190752A1 (en) * 2008-09-05 2010-07-29 Gruenenthal Gmbh Pharmaceutical Combination
WO2011141923A2 (en) 2010-05-14 2011-11-17 Lupin Limited Improved synthesis of optically pure (s) - 3-cyano-5-methyl-hexanoic acid alkyl ester, an intermediate of (s)- pregabalin
WO2012059797A1 (en) 2010-11-04 2012-05-10 Lupin Limited Process for synthesis of (s) - pregabalin

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656177A (en) * 1982-07-22 1987-04-07 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US5248678A (en) 1992-06-30 1993-09-28 Fractal Laboratories, Inc. Methods for increasing arousal and alertness and for the amelioration of comatose states
JPH09502202A (ja) * 1993-09-07 1997-03-04 ザ、プロクター、エンド、ギャンブル、カンパニー プロピオン酸非ステロイド系抗炎症剤のアミノ酸塩とカフェインを含有した組成物
US5443838A (en) * 1993-09-15 1995-08-22 Koenig, Jr.; Steven M. Nutritional supplementation system
EP0888286B1 (en) * 1996-03-14 2001-10-31 Warner-Lambert Company Novel substituted cyclic amino acids as pharmaceutical agents
CA2264182A1 (en) 1996-08-23 1998-02-26 Algos Pharmaceutical Corporation Anticonvulsant containing composition for treating neuropathic pain
WO1998017627A1 (en) 1996-10-23 1998-04-30 Warner-Lambert Company Substituted gamma aminobutyric acids as pharmaceutical agents
US6593368B2 (en) * 1997-09-08 2003-07-15 Warner-Lambert Company Analgesic compositions comprising anti-epileptic compounds and methods of using same

Also Published As

Publication number Publication date
AU772156B2 (en) 2004-04-08
NO20010119D0 (no) 2001-01-08
KR20010071777A (ko) 2001-07-31
NZ508490A (en) 2003-08-29
JP2002520286A (ja) 2002-07-09
EP1094817A1 (en) 2001-05-02
ID28277A (id) 2001-05-10
AU4691099A (en) 2000-02-01
US6326374B1 (en) 2001-12-04
BR9911917A (pt) 2001-03-27
WO2000002562A1 (en) 2000-01-20
PL345340A1 (en) 2001-12-17
ZA200007168B (en) 2002-03-04
CA2332915A1 (en) 2000-01-20
CA2332915C (en) 2006-10-24

Similar Documents

Publication Publication Date Title
IS5525A (is) Innúðabúnaður og aðferð
IS5744A (is) Nýjar 3-arýl-própíónsýruafleiður og -hliðstæður
DK1454907T3 (da) Quninazolin og pyridopyrmidin-derivativer
NO20000700D0 (no) Interleukin-18-proteiner samt fremstilling og anvendelse derav
NO991151D0 (no) Forbindelse og anvendelse derav
NO972911D0 (no) Stabiliserte ribozym-analoger
NO20010119L (no) Preparater omfattende GABA-analoger og kaffein
NO994009D0 (no) Gensekvensator og metoder
NO991150D0 (no) Pyrazolopyrimidiner og pyrazolotriaziner
ITMI982280A0 (it) Alcune n-(2-april-propionil)-solfonammidi e preparazioni farmaceutiche che le contengono
NO983364D0 (no) Konsensusproteiner
MA24473A1 (fr) Formulations
NO20001323D0 (no) Dipeptid-apoptose inhibitorer og deres anvendelse
ATE266383T1 (de) Dermatologische zubereitungen
NO20003312D0 (no) Gamma-glutamyl og beta-aspartyl inneholdende immunmodulator- forbindelser og fremgangsmÕter derav
NO995324L (no) Baerer for gjenstander og emne for denne
NO995683D0 (no) Vitamin D analoger og deres neuronale effekter
NO20000057L (no) Kjernerør
NO993731D0 (no) Pyrrolopyrazolopyrimidin-forbindelse og medisin omfattende denne
DK0826679T3 (da) Naphthylforbindelser og -præparater
DK0929577T3 (da) Stabiliserede proteinholdige protease-inhibitorer og varianter deraf
EE04701B1 (et) Kihisevad preparaadid
DE69806784D1 (de) Spieldose
FI974044A0 (fi) Spis
NO983556L (no) Formulering og anvendelse